Interclass switching with interleukin (IL)-17A and IL-23 inhibitors may be considered a promising strategy versus intraclass switching for patients with psoriasis, according to new findings, and...
Andrea Chiricozzi Credit: sidemast.org An increase in biologic therapy discontinuation is observed among elderly individuals with psoriasis versus younger adult patients, according to new findings, especially...